Angiogenic switching in the alveolar capillaries in primary lung adenocarcinoma and squamous cell carcinoma

Journal of Nippon Medical School

Volumn 74, Issue 5, 2007, Pages 344-354

  Morishita, Chizuko ^a   Jin, Enjing ^a   Kikuchi, Mari ^a   Egawa, Seiko ^a   Fujiwara, Masakazu ^a   Ohaki, Yoshiharu ^b   Ghazizadeh, Mohammad ^a   Takemura, Tamiko ^c   Kawanami, Oichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^c Department of Surgical Pathology   (Japan)

Author keywords

Adenocarcinoma; Alveolar capillary endothelial cell; Angiogenesis; Angiogenic switching; Squamous cell carcinoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CELL MARKER; COLLAGEN TYPE 4; COLLAGEN TYPE 7; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; THROMBOMODULIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ANALYTIC METHOD; ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS; LUNG ALVEOLUS CELL CARCINOMA; MALE; NICK END LABELING; PAPILLARY CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; ANTIGENS, CD31; CAPILLARIES; CARCINOMA, SQUAMOUS CELL; ENDOTHELIAL CELLS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PULMONARY ALVEOLI; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; THROMBOMODULIN; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 34948835763     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.344     Document Type: Article

References (29)

1. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364.
2. Metheny-Barlow LJ, Li LY: The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 2003; 13: 309-317.
3. Folkman J: Tumor angiogenesis: a possible control point in tumor growth. Ann Intern Med 1975; 82: 96-100.
4. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
5. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-248.
6. Gale NW, Yancopoulos GD: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13: 1055-1066.
7. Suri C, Jones PF, Patan S, et al.: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-1180.
8. Maisonpierre PC, Suri C, Jones PF, et al.: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
9. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999; 18: 5356-5362.
10. Holash J, Maisonpierre PC, Compton D, et al.: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998.
11. Jin E, Ghazizadeh M, Fujiwara M, et al.: Angiogenesis and phenotypic alteration of alveolar capillary endothelium in areas of neoplastic cell spread in primary lung adenocarcinoma. Pathol Int 2001; 51: 691-700.
12. Jin E, Fujiwara M, Nagashima M, et al.: Aerogenous spread of primary lung adenocarcinoma induces ultrastructural remodeling of the alveolar capillary endothelium. Hum Pathol 2001; 32: 1050-1058.
13. Kawanami O, Jin E, Ghazizadeh M, et al.: Mosaic-like distribution of endothelial cell antigens in capillaries and juxta-alveolar microvessels in the normal human lung. Pathol Int 2000; 50: 136-141.
14. Jin E, Fujiwara M, Pan X, et al.: Protease-activated receptor (PAR)-1 and PAR-2 participate in the cell growth of alveolar capillary endothelium in primary lung adenocarcinomas. Cancer 2003; 97: 703-713.
15. Koukourakis MI, Giatromanolaki A, Thorpe PE, et al.: Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 2000; 60: 3088-3095.
16. Nakajima M, Kawanami O, Jin E, et al.: Immunohistochemical and ultrastructural studies of basal cells, Clara cells and bronchiolar cuboidal cells in normal human airways. Pathol Int 1998; 48: 944-953.
17. Hasleton PS: Spencer's Pathology of the Lung Fifth edition, 1996; pp 1020-1064, McGraw-Hill Companies, New York.
18. Kawanami O, Ferrans VJ, Crystal RG: Anchoring fibris in the normal canine respiratory system. Am Rev Respir Dis 1979; 120: 595-611.
19. Kawanami O, Ferrans VJ, Roberts WC, Crystal RG, Fulmer JD: Anchoring fibris: A new connective tissue structure in fibrotic lung disease. Am J Pathol 1978; 92: 389-410.
20. Kawanami O, Basset F, Ferrams VJ, Soler P, Crystal RG: Plumonary Langerhans' cells in patients with fibrotic lung disorders. Lab Invest 1981; 44: 227-233.
21. Kawanami O, Ferrans VJ, Crystal RG: Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest 1982; 46: 39-53.
22. Kawanami O: Ultrastructure of the lung in health and in fibrotic diseases. In Basic and Clinical Aspects of Plumonary Fibrosis (Takishima T, ed), 1994; pp 29-73, CRC Press, Boca Raton.
23. Catusse C, Polette M, Coraux C, Burlet H, Birembaut P: Modified basement membrane composition during bronchopulmonary tumor progression. J Histochem Cytochem 2000; 48: 663-669.
24. Wetzels RH, van der Velden LA, Schaafsma HE, et al.: Immunohistochemical localization of basement membrane type VII collagen and laminin in neoplasms of the head and neck. Histopathology 1992; 21: 459-464.
25. Wetzels RH, Robben HC, Leigh IM, Schaafsma HE, Vooijs GP, Ramaekers FC: Distribution patterns of type VII collagen in normal and malignant human tissues. Am J Pathol 1991; 139: 451-459.
26. Wetzels RH, Schaafsma HE, Leigh IM, et al.: Laminin and type VII collagen distribution in different types of human lung carcinoma:correlation with expression of keratins 14, 16, 17 and 18. Histopathology 1992; 20: 295-303.
27. Wetzels RH, Holland R, van Haelst UJ, Lane EB, Leigh IM, Ramaekers FC: Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast. Am J Pathol 1989; 134: 571-579.
28. Nakashima T, Huang CL, Liu D, et al.: Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer. Med Sci Monit 2004; 10: 157-165.
29. Padera TP, Stoll BR, Tooredman JB, Capen D, di Tomaso E, Jain RK: Pathology: cancer cells compress intratumour vessels. Nature 2004; 427: 695.